๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lonidamine combined with cyclofosfamide in treatment of advanced bronchogenic non-small cell carcinoma: Intermediate results of a phase II study in elderly patients

Book ID
123093026
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
128 KB
Volume
7
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of tiazofurin (NSC 286193
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma
โœ Paul Y. Holoye; David T. Carr; Hari M. Dhingra; Bonnie S. Glisson; Jin S. Lee; W ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer US ๐ŸŒ English โš– 115 KB

Fourteen evaluable patients with small cell bronchogenic carcinoma received tiazofurin, an inhibitor of inosine monophosphate dehydrogenase, that progressed after one combination chemotherapy. No objective remission was observed at the dosage of 800 mg/m2 for 5 consecutive days. Toxicity was moderat

Phase II study of recombinant beta inter
Phase II study of recombinant beta interferon in patients with advanced non-small-cell lung carcinoma
โœ Ettinger, David S. ;Harwood, Kerry ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 238 KB

Eighteen patients with advanced non-smallcell lung cancer (NSCLC) received recombinant beta interferon, 90 million units three times weekly. No complete or partial responses were seen. Five patients had stable disease for several months. Most patients experienced some toxicity, most commonly fever a